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Dietary folic acid deficiency induced early hearing loss in C57BL/6J mice after 2-months,
corroborates the epidemiological association previously described between vitamin
deficiency and this sensory impairment. However, this strain is prone to early hearing
loss, and hence we decided to analyze whether the effects exerted by folate deprivation
follow the same pattern in a mouse strain such as CBA/Ca, which is resistant to
hearing impairment. Here, we show results of a long-term study on hearing carried out
on CBA/Ca mice subjected to dietary folate deprivation. Systemic changes included
decreased serum folate levels, hyperhomocysteinemia and signs of anemia in the group
fed with folate-deficient (FD) diet. Initial signs of hearing loss were detected in this strain
after 8-months of vitamin deficiency, and correlated with histological damage in the
cochleae. In conclusion, the data presented reinforce the importance of adequate folic
acid levels for the auditory system and suggest that the impact of dietary deficiencies
may depend on the genetic background.
Keywords: vitamin deficiency, hearing impairment, homocysteine, cochlea, dietary intervention,
hyperhomocysteinemia, folic acid
INTRODUCTION
Hearing loss is a sensory impairment caused by genetic and environmental factors (Dror and
Avraham, 2009; Roth et al., 2011), whose incidence is increasing according to reports of the
World Health Organization. Factors such as noise and ototoxic drugs are well-known effectors
of this impairment, but more recently several epidemiological studies have shown the association
between the nutritional status and hearing loss. Precisely, inadequate levels of folic acid have
been correlated with hearing loss in the presence of reduced vitamin B12 concentrations or
hyperhomocysteinemia (Houston et al., 1999; Cadoni et al., 2004; Lasisi et al., 2010). Additional
reports have explored the putative association of mutations in genes of the folate cycle and the
impact of hearing loss, their results being somewhat inconsistent (Durga et al., 2006; Uchida
et al., 2011). In contrast, two animal studies have demonstrated the link between homocysteine
(Hcy) metabolism and hearing loss (Cohen-Salmon et al., 2007; Martinez-Vega et al., 2015a) and
the effects of a folate-deficient (FD) diet in the auditory system (Martinez-Vega et al., 2015a).
Thus, remarkable increases in auditory brainstem response (ABR) thresholds were detected
in C57BL/6J mice after 2-months on a FD diet (Martinez-Vega et al., 2015a). These changes
correlated with the presence of severe histological damage in the cochlea and with important
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alterations in cochlear metabolism. Folate deficiency induced
a decrease in Hcy remethylation and its flux through trans-
sulfuration, together with an increase in adenosine elimination,
as deduced from the important changes observed in the enzymes
involved. Altogether these changes led to cochlear accumulation
of Hcy, resulting in enhanced protein homocysteinylation, and
in redox stress in FD cochleae (Martinez-Vega et al., 2015a).
C57BL/6J is a strain known to develop premature hearing
loss, a phenotypic trait that was accelerated in FD mice.
Therefore, we set up a new experiment using the CBA/Ca
mouse strain, less prone to hearing loss, to further evaluate
the impact of folate deficiency in the development of this
impairment.
MATERIALS AND METHODS
Mouse Handling and Experimental Design
Two month-old CBA/Ca female mice were purchased from
Harlan Interfauna Ibérica S.A. and housed under standard
conditions. Mice were randomly divided into two experimental
groups (n = 10 each) that were fed the A04/A04C/R04 diet
(Panlab/SAFE) containing standard folate levels (normal folate
2 mg/kg; NF) or a FD diet (folic acid ≤0.1–0.2 mg/kg,
Harlan Tecklad TD.95247) ad libitum for 8 months. Weight
gain was measured weekly for both dietary regimes. All
experiments were approved by the CSIC Bioethics Committee
and carried out in full accordance with the guidelines of the
European Community (2010/63/EU) and the Spanish regulations
(RD 53/2013).
Blood Analysis and Histology
Blood samples were collected through the external maxillary
vein (2-months of age; 2M) or by cardiac puncture after
CO2 asphyxiation (10-months of age; 10M), and directly
placed in either regular or heparin coated tubes (Laboratorios
Farmacéuticos Rovi). Isolation of serum and plasma fractions
was performed after centrifugation at 2500× g for 10 min. The
hematological analysis was performed with Abacus Junior Vet 5
automatic equipment (Diatron). Fresh blood (2/mice) extensions
were prepared for Wright staining (Reagan et al., 2011).
For histological analysis mice were injected a pentobarbital
overdose and perfused with PBS/paraformaldehyde as previously
described (Camarero et al., 2001; Sanchez-Calderon et al., 2010),
before tissue extraction (cochlea and femur; Rodriguez-de la
Rosa et al., 2014). Decalcified samples were dehydrated and
embedded in paraffin (Panreac Química), as previously described
(Aburto et al., 2012). Cochlear and bone marrow cytoarchitecture
was evaluated using representative paraffin sections (7 µm
thick) and Nissl or hematoxylin-eosin staining (Reagan et al.,
2011).
Hearing Assessment
Mice were anesthetized with a mixture of ketamine (100 mg/kg;
Imalgene 1000, Merial) and xylazine (10 mg/kg; Rompun 2%,
Bayer) for ABR analysis using a Tucker Davis Technologies
workstation. The electrical responses to broadband click and
8, 16, 20, 28 and 40 kHz pure tone stimuli, with an
intensity range 90–20 dB SPL in 5–10 dB steps, were recorded
as previously reported (Cediel et al., 2006; Murillo-Cuesta
et al., 2012). The electrical responses were amplified and
averaged to determine hearing thresholds for each stimulus.
Peak and interpeak latencies were analyzed at 15–20 dB SPL
above hearing threshold after click stimulation. Recording
of distortion product otoacoustic emissions (DPOAEs) was
performed after stimulation with f1 and f2 primary tones,
with a ratio f2/f1 = 1.2 using a TDT equipment, as
described previously (Martinez-Vega et al., 2015b). Primary
tones for 8, 10, 14, 18 and 22 kHz frequencies were
tested.
Metabolite Determinations
Total Hcy (tHcy) was derivatized using the Reagent kit for HPLC
analysis of Hcy in plasma/serum (Chromsystems Instruments
and Chemicals GmbH, Munich, Germany). The resulting
samples (50 µl) were then injected into the HPLC column and
fluorescence measured at 515 nm upon excitation at 385 nm.
Total serum folate was determined using the microbiological
method developed by Horne and Patterson (1988) with Tamura’s
modifications (Tamura, 1990).
Statistical Analysis
Statistical analysis was carried out between NF and FD groups at
the specified time points using the Student’s t-test for unpaired
samples was performed with SPSS v 19.0 software package (SPSS,
Chicago, IL, USA). No statistical evaluation was performed
within each dietary group during the whole experiment.
RESULTS
The CBA/Ca mouse strain, known to present with late-onset
of hearing loss (18-months onward; Li and Borg, 1991; Zheng
et al., 1999), was chosen to evaluate the impact of a FD diet
during a long-term study carried out for 8 months. No statistical
differences in the daily food intake were found between NF
and FD groups during the experiment. However, animals in
the FD group gained less weight than those on the NF diet,
this difference becoming significant at 9–10 months of age
(Figure 1A). Nevertheless, both daily ingestion and weight gain
remained above normal values for this strain1.
Additional effects of the dietary treatment were analyzed
in blood samples obtained at the start and the endpoint of
the study (Figure 1B). No differences in serum folate levels
between groups were detected at the beginning of the experiment
(NF-2M vs. FD-2M), whereas a five-fold decrease was measured
in the FD-10M group. This decrease correlated with a seven-fold
increase in tHcy levels in FD-10M mice (Figure 1B), as expected
for the role of folate in Hcy remethylation. Altogether, these
systemic metabolic changes confirmed the efficacy of the dietary
treatment.
1http://www.envigo.com/resources/growth-curves/growth-curve-
cbacaola_505_b2_2013.pdf
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FIGURE 1 | (A) Weight gain along the study. The size of each group is specified in Table 2. Several mice from the folate-deficient (FD) group were sacrificed due to
their condition, and hence the group size was reduced (n = 5) from 7 months of age onward. (B) Serum folate concentrations were measured at 2-months of age
(2M) in the normal folate (NF; n = 9) and FD (n = 5) groups. At 10-months (10M) of age serum folate and homocysteine (Hcy) concentrations were determined in the
NF (n = 9) and FD groups (n = 5). (C) Hematoxylin-eosin staining of bone marrow (a–d) and Wright staining of peripheral blood (f–i) at 10M (n = 5 for both dietary
groups). Megakaryocytes (yellow arrows), scheme of normal erythrocytes and white series (e), anisocytosis and Howell-Jolly bodies (f, arrows). Bar scale 50 µm
(a,c); 25 µm (b,d); 10 µm (remaining panels). Statistical analysis was performed between NF and FD groups at each of the specified time points; no evaluation
within the same dietary groups was performed. ∗∗p < 0.01; ∗∗∗p < 0.001.
FD-10M mice also presented decreased hemoglobin
levels, packed cell volume and hematocrit values, lower
red and white blood cell counts and reduced lymphocyte
percentage, together with increased mean corpuscular volume,
mean corpuscular hemoglobin and an enhanced degree of
anisocytosis (Table 1). Their bone marrow showed a decrease
in megakaryocyte number, which also had lower differentiation
and volume (Figure 1C). Along with these alterations an
increased number of Howell-Jolly bodies, hypersegmented
polymorphonuclear neutrophils and strong anisocytosis were
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TABLE 1 | Blood parameters of CBA/Ca mice.
10 months of age
NF1 (n = 5) FD1 (n = 5)
White blood cells (109/L) 6.36 ± 0.23 3.10 ± 0.52∗∗∗
Red blood cells (1012/L) 9.53 ± 0.12 6.61 ± 0.30∗∗∗
Hemoglobin (g/dL) 14.08 ± 0.34 11.38 ± 0.51∗∗
Hematocrit (%) 46.88 ± 0.80 38.43 ± 1.32∗∗
Mean corpuscular volume (fL) 49.50 ± 0.29 58.25 ± 0.75∗∗∗
Mean corpuscular hemoglobin 30.03 ± 0.45 29.63 ± 0.61
concentration (g/dL)
Mean corpuscular hemoglobin (pg) 14.78 ± 0.25 17.28 ± 0.34∗∗∗
Anisocytosis (%) 17.28 ± 0.28 20.58 ± 0.54∗∗
Granulocytes (%) 22.06 ± 1.01 29.03 ± 2.35
Lymphocytes (%) 75.65 ± 1.36 52.53 ± 7.29∗
Mid-range cells (%) 4.60 ± 1.15 6.43 ± 1.44
Blood parameters were measured at the end of the study, when the mice were 10
months of age, and had been fed the normal (NF) or folate deficient (FD) diets
for 8 months. Statistical analysis was performed between NF and FD groups.
1mean ± SEM; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
observed in peripheral blood extensions of FD-10M mice
(Figure 1C). Altogether, these changes indicated signs of
megaloblastic anemia that jointly with the presence of signs
of stress in the FD-10M mice, led to the interruption of our
study at 10M, despite the late-onset of HL described for
these mice.
The auditory function was evaluated every month in both
dietary groups. No significant changes in ABR threshold,
latencies, or amplitudes were evident between NF and FD mice
along the whole study (Table 2). Both NF-10M and FD-10M
groups showed a decreased amplitude of wave I, which correlated
with a slight increase in hearing thresholds. Histological analysis
revealed damage in the organ of Corti (OC) at the low basal turn
of the cochlea, together with a slight loss in type IV fibrocytes at
the spiral ligament (Spl) and accumulation of melanin granules
in the stria vascularis (StV; Figure 2A). Altogether, these
alterations are indicative of the initial phases of hearing loss
in both dietary groups, but seem more severe in cochleae of
FD mice in which the absence of outer hair cells is noticed
(Figure 2Ag).
The presence of the 2f1-f2 component after pure tone
stimulation was evident in both groups in DPOAE studies.
However, FD-10M mice presented increased DP thresholds
at all the frequencies studied as compared to NF-10M mice,
the differences being significant at 8–14 kHz (Figure 2B).
Concomitantly, decreased 2f1-f2 amplitude was detected in
the FD-10M group, which became significant at 10 kHz
(Figure 2Bb). These results suggested that the initial signs
of hearing loss and the outer hair cell damage were more
pronounced in the FD than in the NF group after 8 months of
nutritional intervention.
DISCUSSION
The relationship between nutritional deficiencies in vitamins,
including folate deficiency, and hearing loss has been explored in
a variety of epidemiological studies (Houston et al., 1999; Cadoni
et al., 2004; Lasisi et al., 2010; Attias et al., 2012; Karli et al., 2013).
However, the data obtained have not always been consistent.
This fact, led several authors to the evaluation of the putative
contribution of human mutations to these disparities and, among
them, the analysis of modifications in key genes of the one-
carbon metabolism. Evaluation of the relationship between
the polymorphism C677T in the methylenetetrahydrofolate
TABLE 2 | Auditory brainstem response (ABR) results at three points of the study.
Age
2 months 7 months 10 months
NF (n = 9) FD (n = 10) NF (n = 9) FD (n = 9) NF (n = 9) FD (n = 5)
ABR1 threshold (dB SPL) Click 16 ± 1 17 ± 1 16 ± 1 18 ± 1 24 ± 1 24 ± 3
8 kHz 22 ± 1 25 ± 0 23 ± 1 23 ± 1 44 ± 4 43 ± 1
16 kHz 21 ± 1 25 ± 2 24 ± 1 25 ± 0 43 ± 5 43 ± 3
20 kHz 21 ± 1 25 ± 0 29 ± 2 27 ± 1 43 ± 2 41 ± 1
28 kHz 23 ± 1 27 ± 1 28 ± 1 28 ± 1 40 ± 2 39 ± 1
40 kHz 28 ± 1 30 ± 2 32 ± 1 29 ± 1 39 ± 2 38 ± 1
Peak latencies1 (ms) Wave I 1.42 ± 0.01 1.33 ± 0.02 1.29 ± 0.04 1.35 ± 0.02 1.39 ± 0.02 1.34 ± 0.04
Wave II 2.42 ± 0.03 2.36 ± 0.02 2.18 ± 0.04 2.31 ± 0.02 2.36 ± 0.03 2.31 ± 0.07
Wave III 3.17 ± 0.04 2.99 ± 0.05 2.87 ± 0.06 2.97 ± 0.03 3.17 ± 0.06 3.20 ± 0.09
Wave IV 4.07 ± 0.03 3.93 ± 0.04 3.90 ± 0.05 3.93 ± 0.02 4.06 ± 0.03 3.99 ± 0.04
Interpeak latencies1 (ms) I–II 1.00 ± 0.02 1.02 ± 0.01 0.98 ± 0.02 0.96 ± 0.01 0.97 ± 0.02 0.97 ± 0.03
I–IV 2.65 ± 0.03 2.60 ± 0.03 2.61 ± 0.03 2.58 ± 0.02 2.68 ± 0.02 2.65 ± 0.03
II–IV 1.65 ± 0.02 1.57 ± 0.02 1.72 ± 0.02 1.62 ± 0.02 1.70 ± 0.02 1.68 ± 0.05
Amplitude1 (nV) Wave I 857 ± 88 729 ± 95 869 ± 217 835 ± 44 553 ± 39 424 ± 57
Wave II 1474 ± 153 1285 ± 128 922 ± 147 1035 ± 73 961 ± 79 964 ± 90
Wave III 150 ± 44 188 ± 52 278 ± 66 288 ± 65 192 ± 35 224 ± 60
Wave IV 1278 ± 175 1105 ± 104 1227 ± 210 1449 ± 106 746 ± 94 797 ± 129
Hearing parameters were measured during the whole study in the normal (NF) and folate deficient (FD) dietary groups, although only three key points of the experiment
that correspond to the start, 5 and 8 months of diet administration (2, 7 and 10 months of age) are shown. 1mean ± SEM.
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FIGURE 2 | Representative histological images of the Nissl-stained basal regions and distortion product otoacoustic emissions (DPOAE) results. (A)
General views of the cochlear basal turn (a,f) for NF (n = 3) and FD mice (n = 3) 10-months old. Detailed views of the organ of Corti (OC; b,g), where collapse of the
inner and outer pillar cells is observed in both dietary groups (#) and the presence of outer hair cells in the NF (arrows) and their absence in the FD group (∗∗∗) are
indicated. Additional subpanels show detailed views of the stria vascularis (StV; c,h) with melanin granules in both dietary groups (arrows); spiral ligament (Spl; d,i)
and cochlear ganglion (CG; e,j). Bar scale: 150 µm (a,f); 25 µm (remaining panels). (B) DPOAE analysis at 2- (2M; NF n = 9 and FD n = 10) and 10-months (10M;
NF n = 9 and FD n = 5) of age; DP thresholds (a) and 2f1-f2 amplitudes (b) are shown (mean ± SEM). ∗p < 0.05.
reductase gene, a key player in folate metabolism, and hearing
loss rendered contradictory results (Durga et al., 2006; Uchida
et al., 2011; Fusconi et al., 2012). In contrast, animal studies have
provided clues to the interplay between folate, Hcy and hearing
loss, showing alterations in Hcy metabolism correlating with the
onset of this impairment (Cohen-Salmon et al., 2007; Kundu
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et al., 2012; Martinez-Vega et al., 2015a). In this line of evidence,
a previous study using the C57BL/6J mouse strain, known by its
early onset of hearing loss, showed that a decrease in folate intake
accelerates development of this sensory decline (Martinez-Vega
et al., 2015a). A fact that correlated with a systemic decrease of
the vitamin levels and concomitant hyperhomocysteinemia, as
expected from the critical role of folate in Hcy remethylation
(Pajares and Pérez-Sala, 2006). These systemic changes are
also detected in the present study using CBA/Ca mice during
long-term feeding with a folate deprived diet, following the
same trend than in C57BL/6J mice after 2 months of FD diet
(Martinez-Vega et al., 2015a). However, hyperhomocysteinemia
was more severe in CBA/Ca mice after 8 months on the FD diet
than in C57BL/6J mice after 2 months (Martinez-Vega et al.,
2015a).
Folate deficiency induced premature signs of hearing loss in
both strains, although their appearance is delayed more than
6 months in the CBA/Ca strain as compared to C57BL/6J
mice (Martinez-Vega et al., 2015a). Moreover, the extent of
the damage is also very different, since most C57BL/6J mice
showed profound hearing loss after 2 months on the FD diet
(Martinez-Vega et al., 2015a), whereas the changes in hearing
parameters in CBA/Ca mice are small, but consistent (increased
DP thresholds and 2f1-f2 amplitude) and appear after 8 months
on the deficient diet. In fact, histological data corroborated
cochlear damage in CBA/Ca mice that was more evident
in the FD animals. Folate-induced damage seemed restricted
to the low basal turn of the cochlea, thus explaining that
stimulation required high frequency sounds (Müller et al., 2005).
This higher resistance of the CBA/Ca cochleae against vitamin
deficiency may rely in differences in the genetic background of
the strains used that remain largely unknown (Willott et al.,
1995).
The high resistance against FD-induced hearing loss exhibited
by CBA/Ca mice, as compared to the C57BL/6J strain used in our
previous work (Martinez-Vega et al., 2015a), suggested putative
differences in genes involved in folate metabolism. However, the
small size of the mouse cochleae and the histological procedures
carried out precluded an expression study on the remaining
samples. Nevertheless, a search carried out into the Mouse
Genome Project database showed a number of single nucleotide
polymorphisms (SNPs) on several genes of folate metabolism
in CBA/J mice as compared to the reference C57BL/6J strain
(Keane et al., 2011). No differences in Mtr, Bhmt, Dhfr, Tyms,
Mthfd1 and Mthfd2 genomic sequences were found between
both strains (Table 3). In contrast, several SNPs for Bhmt2,
Folr1, Folr2, Mtrr, Mthfr, Shmt1 and Shmt2 were identified.
Among them, a missense mutation on Folr1 for which the
functional impact remains unknown, and those on Bhmt2, a
gene whose hepatic expression levels have been proposed as
a dietary-dependent factor conferring protection against drug
intoxication (Liu et al., 2010). In this work, Liu et al. (2010)
suggested that strains with higher hepatic BHMT2 levels/activity
would be adapted for a lower dependence on folate for Hcy
recycling by the use of S-methylmethionine as methyl donor.
Clarification on whether this postulate is valid for the auditory
system would require an extensive work on genomic sequencing
TABLE 3 | Single nucleotide polymorphisms (SNPs) for key genes of folate
metabolism detected in CBA/J mice according to the Mouse Genome
Project.
Gene Base in SNP Base in Main change
C57BL/6J CBA/J
Folr1 G rs47738978 A∗ 3’-UTR
A rs47631647 G∗ missense F236L
G rs47445319 A∗ upstream 2KB
A rs49747152 G∗ upstream 2KB
C rs50854846 A intron
C rs52411810 A intron
A rs586270005 T intron
C rs52321323 T intron
C rs52448898 A∗ upstream 2KB
G rs240085681 C intron
G rs262701625 A intron
Folr2 C rs32160123 G∗ intron
C rs31011801 T∗ intron
A rs31275071 C∗ intron
T rs48667177 A∗ intron
Bhmt2 C rs264842124 T downstream 500B
T rs47046885 C 3’-UTR
Mthfr A 148039163a G∗ unknown
G 148039229a C∗
C 148039557a G
C 148040119a T
C 148040240a T
Mtrr T rs108123629 t/a 3’-UTR
C rs108647820 c/a 3’-UTR
G rs108535269 G 3’-UTR
T rs108864771 T 3’-UTR
Shmt1 A rs26957199b G∗ 3’-UTR
A rs47721266 C∗ downstream 500B
A rs49213375 C∗ downstream 500B
T rs222704054 C∗ downstream 500B
A rs222753876 G∗ downstream 500B
A rs108000000 G∗ downstream 500B
C rs26957196 A∗ downstream 500B
G rs45981582 A∗ downstream 500B
G rs26957195 A∗ downstream 500B
Shmt2 G rs252755979b T∗ 3’-UTR
C rs240177349b T∗ 3’-UTR
C rs51081486b T∗ 3’-UTR
A rs47587430 G∗ 3’-UTR
C rs260368105 T∗ 3’-UTR
G rs49954613 C∗ 3’-UTR
The table shows results of a search for SNPs in key genes of folate
metabolism of CBA/J mice carried out in The Mouse Genome Project web
page (http://www.sanger.ac.uk/science/data/mouse-genomes-project), where the
C57BL76J strain is used as reference. ∗Multiple consequences, only the main one
listed. aNumber indicates position. bGene assignment differs between MGP and
NCBI databases.
and evaluation of several SNPs that is out of the scope of the
present article.
Despite the interest of a prolonged study to get deeper
insight the interplay between Nutrition and cochlear aging,
the continuity of this long-term nutritional treatment was
precluded by the presence of megaloblastic anemia. This fact
was described in previous studies analyzing low intakes of folate
or vitamin B12 for extended periods of time (Cox et al., 1961;
Bills et al., 1992), but was not evident in C57BL/6J mice after
2 months of diet (Martinez-Vega et al., 2015a). Altogether,
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our data support the role of folate deficiency in premature
development of hearing loss, although new experiments aimed
to analyze its impact in strains with delayed onset of this sensory
impairment should consider beginning nutritional interventions
at later stages of animal development. Moreover, studies on
the putative value of folate supplementation against hearing
loss are needed, as well as the analysis of the incidence of this
sensory decline in human populations living in countries with
mandatory folate fortification for which only preliminary data
are available: http://www.cdc.gov/ncbddd/hearingloss/data.html.
In this line, nutrigenomic studies may render clues about
the interaction between folate deficiency and the cochlear
genome.
CONCLUSION
The results presented herein reinforce the crucial role of folic
acid status in the cochlea. Moreover, our data suggest that
differences encountered in animal and human studies analyzing
the interplay between nutritional deficiencies and hearing loss,
especially in age-related hearing loss, may depend on the
combinatory effects of both diet and genetic background.
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